A center-based, ambulatory care concept for hidradenitis suppurativa improves patient outcomes and is also cost-effective

A center-based, ambulatory care concept for hidradenitis suppurativa improves patient outcomes and is also cost-effective

AbstractBackground Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease affecting approximately 1% of the population. The patient journey through the German health care system leads to high disease burden and substantial treatment costs. The EsmAiL study showed that an innovative, in...

Full description

Bibliographic Details
Main Authors: Marcus Heise, Petra Staubach, Georgios Nikolakis, Lukas Schollenberger, Melanie Mauch, Marion Burckhardt, Marina Zamsheva, Alexandra Strobel, Gero Langer, Falk Bechara, Uwe Kirschner, Katharina Hennig, Christian Kunte, Matthias Goebeler, Maurizio Podda, Stephan Grabbe, Michael Schultheis
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Journal of Dermatological Treatment
Subjects:
Hidradenitis suppurativa
treatment costs
innovative care concept
ambulatory care
Online Access:https://www.tandfonline.com/doi/10.1080/09546634.2023.2284105

Internet

https://www.tandfonline.com/doi/10.1080/09546634.2023.2284105

Similar Items